Doccla
Healthcare. Redefined.
London, United Kingdom · Founded 2019 · $73.0M raised
- Headquarters
- London
- Employees
- 51–200
- Founded
- 2019
- Business Model
- B2B
- Website
- doccla.com
- Total Funding
- $73.0M
- Last Round
- $45.9M Series BSep 2024
- Rounds
- 4
About
Doccla is Europe's leading Virtual Care provider, founded in 2019 and headquartered in London, United Kingdom. The company enables hospitals and health systems to care for patients at home through virtual wards and remote monitoring, supporting patients across the full care journey—from early discharge and acute recovery to long-term condition management and proactive care. Doccla provides everything clinicians need for safe, effective virtual care, including medical-grade devices, logistics, patient onboarding, EHR integration, and a CQC-registered clinical team of nurses, GPs, and consultants. Trusted by over 60% of NHS Integrated Care Boards, Doccla has raised a $46M Series B to scale its platform across the UK, Ireland, and wider Europe.
Summary
Doccla is a Life Sciences company based in London, United Kingdom, founded in 2019. It has raised $73.0M in total across 4 rounds, most recently a $45.9M Series B round in Sep 2024. Investors include General Catalyst, Lakestar and Bertelsmann Investment.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Alphabet-backed biotechnology company researching biology of aging and developing interventions t...

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
